Abstract
Background. Whether or not
hypovitaminosis D can influence the prognosis of cancer patients and
whether or not vitamin D (vitD) supplementation
improves outcome remain controversial.
Conclusion. Hypovitaminosis D seems to be associated
with a worse prognosis in some cancers, but vitD supplementation failed
to demonstrate
a benefit in prostate cancer patients. The
currently available evidence is insufficient to recommend vitD
supplementation
in cancer patients in clinical practice.
Note: per reference, one study included - ovarian cancer
(Tamez S, Norizoe C, Ochiai K et al. Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer 2009; 101:1957–1960.)
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.